MSc Clinical Drug Development in London United Kingdom | Queen Mary University of London

The MSc in Clinical Drug Development equips students with a multidisciplinary approach to enhance their expertise. This program caters to professionals seeking comprehensive knowledge of pharmaceutical development, offering an in-depth exploration of the interconnected processes involved in bringing drugs and biologics from discovery to market. The curriculum prepares graduates to meet pharmaceutical industry demands by developing specialized competencies for career advancement in pharmaceutical companies, contract research organizations (CROs), or healthcare settings.Program OverviewOur structured postgraduate course in clinical drug development delivers both theoretical knowledge and practical skills essential for conducting clinical research. The flexible modular format accommodates working professionals, with intensive three-day teaching sessions scheduled every four to six weeks.Curriculum HighlightsThe initial curriculum focuses on foundational drug development concepts. Students will master clinical study design principles and acquire hands-on experience with early-stage development processes. The program covers ethical considerations, regulatory frameworks, and data management techniques while providing broader perspectives on drug discovery, preclinical research, and toxicology studies.